Literature DB >> 14643774

Exacerbated status epilepticus and acute cell loss, but no changes in epileptogenesis, in mice with increased brain-derived neurotrophic factor signaling.

S Lähteinen1, A Pitkänen, E Koponen, T Saarelainen, E Castrén.   

Abstract

Several studies suggest that brain-derived neurotrophic factor (BDNF) can exacerbate seizure development during status epilepticus (S.E.) and subsequent epileptogenesis in the adult brain. On the other hand, evidence exists for the protective effect of BDNF. To study this controversy, we induced S.E. with kainate in transgenic mice with increased BDNF signaling due to trkB overexpression. Transgenic mice experienced a more severe S.E. than wild type animals did. Furthermore, they had increased acute hippocampal neuronal loss when assessed at 48 h after S.E. The effect of trkB overexpression on the development of epilepsy, chronic neuronal death, mossy fiber sprouting, and neurogenesis were studied at 4.5 months after kainate-induced S.E. No differences were found in the rate of epileptogenesis, severity of epilepsy, or cellular markers of network reorganization between transgenic and wild type mice. No differences between genotypes were observed in TUC-4 staining, indicating no effect of trkB overexpression to immature neuron numbers. Instead, in Cresyl Violet-stained preparations, the highest density of neurons was found in untreated transgenic mice suggesting a favorable effect of trkB overexpression on the survival of neurons in the hippocampus. Our data support the role of BDNF and trkB signaling in seizure generation and acute cellular damage after S.E. Long-term outcome was not, however, exacerbated by trkB overexpression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14643774     DOI: 10.1016/j.neuroscience.2003.08.037

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  RNA aptamer-based functional ligands of the neurotrophin receptor, TrkB.

Authors:  Yang Zhong Huang; Frank J Hernandez; Bin Gu; Katie R Stockdale; Kishore Nanapaneni; Todd E Scheetz; Mark A Behlke; Andrew S Peek; Thomas Bair; Paloma H Giangrande; James O McNamara
Journal:  Mol Pharmacol       Date:  2012-06-29       Impact factor: 4.436

2.  Is the tyrosine kinase B receptor a target for preventing epilepsy?

Authors:  Catherine Croft Swanwick; Jaideep Kapur
Journal:  Epilepsy Curr       Date:  2005 Jan-Feb       Impact factor: 7.500

3.  Altered morphology of hippocampal dentate granule cell presynaptic and postsynaptic terminals following conditional deletion of TrkB.

Authors:  Steve C Danzer; Robert J Kotloski; Cynthia Walter; Maya Hughes; James O McNamara
Journal:  Hippocampus       Date:  2008       Impact factor: 3.899

4.  Aging-induced Seizure-related Changes to the Hippocampal Mossy Fiber Pathway in Forebrain Specific BDNF Overexpressing Mice.

Authors:  Kate L Weidner; Jeffrey H Goodman; Kathryn K Chadman; Daniel P McCloskey
Journal:  Aging Dis       Date:  2011-08-30       Impact factor: 6.745

5.  Brain-derived neurotrophic factor and epilepsy--a missing link?

Authors:  Helen E Scharfman
Journal:  Epilepsy Curr       Date:  2005 May-Jun       Impact factor: 7.500

Review 6.  Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Front Neuroendocrinol       Date:  2006-10-20       Impact factor: 8.606

7.  Novel Targets for Developing Antiseizure and, Potentially, Antiepileptogenic Drugs.

Authors:  Dipan C Patel; Karen S Wilcox; Cameron S Metcalf
Journal:  Epilepsy Curr       Date:  2017 Sep-Oct       Impact factor: 7.500

Review 8.  Molecular pathways controlling inhibitory receptor expression.

Authors:  Heidi L Grabenstatter; Shelley J Russek; Amy R Brooks-Kayal
Journal:  Epilepsia       Date:  2012-12       Impact factor: 5.864

9.  Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.

Authors:  Julio Licinio; Chuanhui Dong; Ma-Li Wong
Journal:  Arch Gen Psychiatry       Date:  2009-05

Review 10.  Role of Liver Growth Factor (LGF) in Parkinson's Disease: Molecular Insights and Therapeutic Opportunities.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  Mol Neurobiol       Date:  2021-02-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.